🇺🇸 FDA
Patent

US 12226455

Medical composition for treating cardiac wasting and cachexia

granted A61KA61K38/2221A61P

Quick answer

US patent 12226455 (Medical composition for treating cardiac wasting and cachexia) held by RELAXERA PHARMAZEUTISCHE GMBH & CO. KG expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RELAXERA PHARMAZEUTISCHE GMBH & CO. KG
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/2221, A61P, A61P9/02, A61P9/04